February 13, 2019 / 9:37 PM / 2 days ago

BRIEF-Novartis Receives FDA Approval For Egaten For Treatment Of Fascioliasis

Feb 13 (Reuters) - Novartis AG:

* NOVARTIS RECEIVES FDA APPROVAL FOR EGATEN FOR THE TREATMENT OF FASCIOLIASIS, A NEGLECTED TROPICAL DISEASE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below